Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A.

Slough

Hybride

GBP 90 000 - 130 000

Plein temps

14 jours+

Obtenez une réponse de cet employeur

Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.

Passez les filtres ATS

Avantages offerts par ce poste

Hybrid work model
Global exposure

Résumé du poste

UCB S.A. is seeking a strategic HEOR Strategy Lead to shape global payer evidence and HTA strategies across the product lifecycle. You will join the Patient Evidence team and influence development and commercialization with evidence generation plans.

Based in Brussels, Slough, or Monheim, this hybrid role offers collaboration across markets and functions, including real world evidence, medical affairs, and clinical development.

Qualifications

  • Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or related field.
  • 8+ years of pharma industry experience, including consultancy where relevant.
  • Experience in global or matrix organizations with intercontinental exposure.

Responsabilités

  • Develop and refine global HEOR and payer evidence strategies aligned with asset and market access objectives.
  • Design and deliver HEOR evidence generation activities including cost-effectiveness and budget impact models, literature reviews, and QoL studies.
  • Build asset value assessments and support pricing and value strategies.
  • Communicate economic value stories for assets and indications.
  • Influence clinical development programs to meet payer HTA requirements globally.
  • Represent HTA and payer perspectives within cross-functional teams.

Connaissances

Health economics
Outcome research
Strategic thinking
Stakeholder management
Leadership
Communication skills

Formation

Master's degree or PhD in Health Economics or related field

Outils

HEOR modelling tools

Description du poste

UCB S.A. is seeking a strategic HEOR Strategy Lead to shape global payer evidence and HTA strategies across the product lifecycle. You will join the Patient Evidence team and influence development and commercialization with evidence generation plans.

Based in Brussels, Slough, or Monheim, this hybrid role offers collaboration across markets and functions, including real world evidence, medical affairs, and clinical development.

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Global HEOR Strategy Lead: Payer Evidence & Access
Global HEOR Strategy Lead: Payer Evidence & Access

UCB • Slough

Hybride
GBP 90 000 - 130 000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB • Slough

Hybride
GBP 90 000 - 130 000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB S.A. • Slough

Hybride
GBP 90 000 - 130 000
Hybrid work model
Global exposure
Senior HEOR Expert – Rare Disease, Global Access
Senior HEOR Expert – Rare Disease, Global Access

UCB • Slough

Hybride
GBP 90 000 - 130 000
Global Payer Strategy & Access Lead
Global Payer Strategy & Access Lead

Ucb • Slough

Hybride
GBP 136 000 - 182 000
Global Access & Pricing Strategy Lead – Immunology
Global Access & Pricing Strategy Lead – Immunology

UCB • Slough

Hybride
GBP 120 000 - 170 000
Hybrid work model
Reasonable accommodation process
Global Access & Pricing Strategy Lead - Neurology
Global Access & Pricing Strategy Lead - Neurology

UCB • Slough

Hybride
GBP 90 000 - 130 000
Global Payer Strategy & Access Lead
Global Payer Strategy & Access Lead

UCB • Slough

Hybride
GBP 150 000 - 190 000
Access & Pricing Strategy Lead - Neurology (United Kingdom)
Access & Pricing Strategy Lead - Neurology (United Kingdom)

UCB • Slough

Hybride
GBP 120 000 - 150 000
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)

UCB • Slough

Hybride
GBP 90 000 - 130 000